Big Moves in Focus: The Gap (NYSE:GPS), Motorola Solutions (NYSE:MSI), Rally Software Development (NYSE:RALY), Aeterna Zentaris (NASDAQ:AEZS), Johnson & Johnson (NYSE:JNJ)


Gap Inc. (NYSE:GPS) mentioned late Thursday that a crucial revenue metric rose three % for the November and December period, as surging sales at its low-priced Old Navy chain offset sluggish company at its namesake small business. For December alone, the figure rose 1 percent, slightly above Wall Street estimate for a .7 % increase, according to Thomson Reuters. The Gap, Inc. (NYSE:GPS) in last trading activity fell -1.15% to close at $43.10. Company weekly performance is 2.89% while its quarterly performance stands at 3.41%. The Gap, Inc. (NYSE:GPS) is -7.03% away from its 52 week high.

Motorola Solutions, Inc. (NYSE:MSI), a leading provider of mission-critical communication solutions and services for public safety and commercial customers, through its investment arm Motorola Solutions Venture Capital has invested in VocalZoom Ltd., a leading developer of sensors for speech enhancement. The terms of the transaction were not disclosed. On last trading day Motorola Solutions, Inc. (NYSE:MSI) advanced 1.55% to close at $65.43. Its volatility for the week is 1.79% while volatility for the month is 1.59%. MSI’s sales growth for past 5 years was 2.00% and its EPS growth for past 5 years was 18.90%. Motorola Solutions, Inc. (NYSE:MSI) monthly performance is 0.79%.

Rally Software Development Corp (NYSE:RALY) has received an average rating of “Buy” from the seven ratings firms that are currently covering the stock, Analyst Ratings.Net reports. Three investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $19.10.Rally Software Development Corp. (NYSE:RALY) has 3.40% insider ownership while its institutional ownership stands at 75.60%. In last trading activity company’s stock closed at $11.72.

Glancy Binkow & Goldberg LLP announces that a class action complaint has been filed with an expanded Class Period in the shareholder lawsuit pending in the United States District Court for the District of New Jersey against Aeterna Zentaris Inc. (NASDAQ:AEZS). The complaint alleges violations of federal securities laws and asserts claims on behalf of purchasers of Aeterna securities between April 2, 2012 and November 6, 2014, inclusive (the “Class Period”).On Thursday shares of Aeterna Zentaris Inc. (NASDAQ:AEZS) closed at $0.59. Company’s sales growth for last 5 years was -30.60%.

Johnson & Johnson (NYSE:JNJ) has begun testing an Ebola vaccine in humans intended to counter a strain of the virus similar to the one that has wreaked havoc in West Africa.On last trading day Johnson & Johnson (NYSE:JNJ) advanced 0.79% to close at $106.39. Its volatility for the week is 1.40% while volatility for the month is 1.57%. JNJ’s sales growth for past 5 years was 2.30% and its EPS growth for past 5 years was 1.00%. Johnson & Johnson (NYSE:JNJ) monthly performance is -1.96%.


Leave a Reply

Your email address will not be published. Required fields are marked *